Production & Sales

Quotient and Ipsen extend partnership for ultra-rare disease therapy

Quotient Sciences has extended its commercial partnership with Ipsen, focusing on the production of Sohonos (Palovarotene) for fibrodysplasia ossificans progressiva (FOP).

Citius Oncology and Uniphar sign European distribution deal for Lymphir

Citius Pharmaceuticals’ subsidiary Citius Oncology has signed an exclusive distribution agreement with Uniphar to enable access to Lymphir (denileukin diftitox-cxdl) in selected European countries.

BMS reports flat revenue growth for full-year 2025

Bristol Myers Squibb (BMS) has reported full-year 2025 revenues of $48.2bn, essentially flat compared with $48.3bn in 2024.

IQVIA and Boehringer Ingelheim collaborate on therapeutic data transformation

IQVIA has announced a strategic, long-term partnership with Boehringer Ingelheim focused on strengthening data capabilities across therapeutic areas. 

Johnson & Johnson reports 9.1% increase in sales for Q4 2025

Johnson & Johnson (J&J) has reported a 9.1% increase in sales for Q4 2025, reaching $24.56bn, with net earnings rising by 49.1% to $5.11bn.

AstraZeneca to acquire China rights for AbelZeta’s CAR-T therapy

AstraZeneca has agreed to purchase AbelZeta’s 50% stake in the China development and commercialisation rights for C-CAR031.

Agenus and Zydus complete $141m BOT+BAL immunotherapy collaboration deal

Agenus has completed a $141m strategic collaboration with Zydus Lifesciences to accelerate the global development and potential commercialisation of its botensilimab and balstilimab (BOT/BAL) immunotherapy combination programme.

BD invests $110m to expand US prefillable syringe production

BD (Becton, Dickinson and Company) has announced a $110m investment to expand its production of prefillable syringes in the US.

Santhera grants Agamree rights to Nxera for DMD

Santhera Pharmaceuticals has entered an exclusive licensing agreement with Nxera Pharma for Agamree (Vamorolone) to treat Duchenne muscular dystrophy (DMD) in Australia, Japan, New Zealand, and South Korea.